Status:
COMPLETED
Femoral Nerve Blockade in Endovenous Laser
Lead Sponsor:
Helsinki University Central Hospital
Conditions:
Pain
Eligibility:
All Genders
20-70 years
Phase:
NA
Brief Summary
Varicose veins affect a majority of adult population in the western world. They decrease quality of life and may also cause venous ulcers. Therefore varicose vein treatments are justified. Currently e...
Detailed Description
Varicose veins affect a majority of adult population in the western world. They decrease quality of life and may also cause venous ulcers. Therefore varicose vein treatments are justified. Thanks to ...
Eligibility Criteria
Inclusion
- Great saphenous vein insufficiency
- CEAP class 2-4
Exclusion
- Neurological diseases
- Pregnancy
- CEAP 5-6
- BMI\>40
- Allergy to lidocain
Key Trial Info
Start Date :
March 13 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2021
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT03475641
Start Date
March 13 2017
End Date
December 31 2021
Last Update
August 9 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Helsinki University Hospital, Finland
Helsinki, Uusimaa, Finland, 00029